Health
Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia – Wiley
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The…
Adults and children with acute leukaemia are at high risk of serious illness and death from COVID-19, compared with the general population.1, 2 Furthermore, delayed or interrupted leukaemia treatment due to SARS-CoV-2 infection may also result in poor prognosis,…
Continue Reading